22.02.2015 Views

Biosafety Manual PDF - Lawrence Berkeley National Laboratory

Biosafety Manual PDF - Lawrence Berkeley National Laboratory

Biosafety Manual PDF - Lawrence Berkeley National Laboratory

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

<strong>Biosafety</strong> <strong>Manual</strong><br />

IBC-approved version (May 18, 2010)<br />

Additional instruction or demonstration of proficiency may be needed for work that involves<br />

higher hazards. For example, workers must demonstrate their proficiency in standard<br />

microbiological practices and special practices before working with RG2 agents (for more<br />

information, see Section 4.1 of this manual).<br />

Labels and signs must also be used to advise workers of hazards and controls (see Section 5.5<br />

of this manual).<br />

5.3 Occupational Health and Immunization<br />

LBNL occupational health and immunization policies, programs, and services are provided by<br />

the Health Services Group of the EH&S Division under the direction of the Site Occupational<br />

Medical Director. These policies, programs, and services are described in the Health Services<br />

Web site, policies (e.g., immunization and serum banking), and Chapter 3 of PUB-3000. The<br />

occupational health program related to biosafety is designed to proactively identify and prepare<br />

workers who may be exposed to certain biological materials or agents, and provide procedures<br />

for the treatment and management of workers who have been injured or may have been<br />

exposed. Employees who are aware of personal illnesses that may affect their ability to combat<br />

infection or receive medications or vaccines should visit Health Services for an evaluation of<br />

how this may affect their individual risk for work with biological agents.<br />

Potential exposures to biological agents or materials that generate health concerns or may<br />

cause disease are assessed as part of the work review and authorization process discussed<br />

above in Sections 3.0 and 5.1. This assessment includes an evaluation and determination of the<br />

need for employee medical evaluations, immunizations, serum banking, or other occupational<br />

health controls. For research projects, this assessment is conducted by IBC members including<br />

the <strong>Biosafety</strong> Officer and the SOMD. The IBC review includes SOMD recommendations and is<br />

the basis of required or recommended occupational health controls for potentially exposed<br />

employees. These controls are then documented in the <strong>Biosafety</strong> Work Authorization.<br />

Employee consultation with LBNL Health Services. Source: LBNL EH&S.<br />

Requirements or recommendations for occupational health controls (e.g., vaccinations) for<br />

specific agents or materials are discussed in BMBL, Section VIII (Agent Summary Statements).<br />

Requirements for BBP materials are provided by the OSHA Bloodborne Pathogens Standard.<br />

OSHA requirements and LBNL programmatic policies and systems for implementing these<br />

requirements are summarized below:<br />

• Hepatitis B Vaccination: The OSHA Bloodborne Pathogens Standard requires that the<br />

hepatitis B vaccination series must be made available and offered to all LBNL<br />

employees who have occupational exposure to BBPs or materials that are regulated<br />

based on their potential to contain BBPs (e.g., human blood, tissues, and cells). This<br />

Printed copies are not official versions of this manual. Before using the printed copy, verify that it is the most current version.<br />

42

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!